Immunogenicity of 2-dose pre-exposure rabies vaccine co-administered with quadrivalent influenza vaccine in children
Objectives: The World Health Organization recommends a 2-dose rabies pre-exposure prophylaxis (PrEP) regimen. This study aimed to compare the immunogenicity of rabies PrEP regimens co-administered with inactivated quadrivalent influenza vaccine (IIV4). Methods: Children aged 3 to 9 years were random...
Guardado en:
Autores principales: | Napaporn Chantasrisawad, Watsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Suda Punrin, Kornvika Limsuwun, Panadda Sawangsinth, Chayapa Phasomsap, Jiratchaya Sophonphan, Chitsanu Pancharoen, Thanyawee Puthanakit |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d9801c6b7bc4308b1f59922fb6dcaa4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluacion de la capacidad inmunogénica de la vacuna antirrábica tipo Fuenzalida- Palacios (CRL) y de la vacuna antirrábica de cultivo celular (Verorab®) en personas con tratamiento preexposición
por: Favi C,Myriam, et al.
Publicado: (2004) -
Travelers’ vaccines and their adverse events in Nara, Japan
por: Ogawa Taku, et al.
Publicado: (2021) -
BIOTECHNOLOGICAL RESEARCH IN THE CREATION AND PRODUCTION OF ANTIRABIC VACCINES
por: Krasnopolsky Yu. М., et al.
Publicado: (2021) -
Risk factors associated with nonvaccination rabies status of dogs in KwaZulu-Natal, South Africa
por: Hergert M, et al.
Publicado: (2016) -
Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine
por: Asgary V, et al.
Publicado: (2016)